No, von Willebrand disease is NOT a hypercoagulable condition—it is a bleeding disorder.
Von Willebrand disease (VWD) is definitively a bleeding disorder caused by deficiency or dysfunction of von Willebrand factor (VWF), not a hypercoagulable state. VWD is characterized by excessive mucocutaneous bleeding including easy bruising, epistaxis, heavy menstrual bleeding, and prolonged bleeding after surgery or trauma 1.
Why VWD is a Bleeding Disorder
VWD results from either:
- Quantitative deficiencies (Types 1 and 3): reduced or absent VWF levels
- Qualitative deficiencies (Type 2): dysfunctional VWF despite adequate levels 1
The clinical manifestations are exclusively bleeding-related:
- Easy bruising and epistaxis
- Prolonged bleeding from minor wounds
- Heavy menstrual bleeding in women
- Gastrointestinal bleeding
- Excessive bleeding after dental work, surgery, and childbirth
- In severe cases, musculoskeletal bleeding 1, 2
The Rare Exception: Thrombosis Can Occur But Is Not the Disease Itself
While VWD is fundamentally a bleeding disorder, thrombotic events have been rarely reported in the literature but are exceptional complications, not characteristic features 3. A critical review identified only 30 total cases of thrombosis in VWD patients ever reported—11 arterial and 19 venous 3.
Key Context for These Rare Thrombotic Events:
These thromboses occurred with significant confounding risk factors, not from VWD itself:
- Infusion of FVIII or VWF concentrates (7 cases)
- Surgery (8 cases)
- Coagulation defects or polymorphisms (5 cases)
- Desmopressin infusion
- Pregnancy
- Traditional cardiovascular risk factors (smoking, dyslipidemia) 3
The thrombosis rate in VWD is actually lower than in hemophilia A and B, confirming that VWD does not confer hypercoagulability 3.
Clinical Pitfall to Avoid
Do not confuse the physiological increase in VWF levels during pregnancy (which creates a temporary hypercoagulable state in normal pregnancy) with VWD itself. Women with VWD may see their VWF levels rise during pregnancy, but they remain at increased risk for postpartum hemorrhage, not thrombosis 4. The primary concern remains bleeding, particularly in the postpartum period when VWF levels drop rapidly 4.
The Opposite Concept: Elevated VWF as a Thrombotic Risk
Conversely, elevated plasma VWF levels (the opposite of VWD) are associated with increased arterial thrombotic risk 5. This further confirms that VWD—characterized by low or dysfunctional VWF—is protective against thrombosis, not causative of it.